3200 W Liberty Rd., Suite C5 
Ann Arbor, MI 48103

(734) 222-9630
info@fivensondermatology.com

Free
Care

No
Insurance Needed

Trial includes
compensation for your time

Enroll Now

Lupus

When you have lupus, you never know when a flare will strike or how it will affect you. If you have cutaneous lupus erythematosus (CLE), you may be eligible to participate in a clinical trial – now accepting participants. You may even be able to remain on current lupus treatments while participating.

Enroll Today

Prurigo Nodularis
(aka pickers bumps)

Participants must be adults ages 18-75, have more than 20 active sites involving at least 2 body regions. This is a double-blind study of an oral daily medication with 2 different doses vs placebo for 24 weeks. After 24 weeks, all subjects get active medicine. All participants paid for visits with compensation available for travel.
Enroll Today

Psoriasis

This study is a registry to track symptoms and progress of patients who start on some of the newer immunosuppressive agents for treatment.

Enroll Today

Psoriasis

Participants must be adults ages 1+, have more than 10% body surface area plaque psoriasis (10 handprints of involved area). This is a double-blind study of an oral daily medication comparing the study medicine to Otezla and placebo with 4:1 ratio of active agents to placebo for 16 weeks. After 16 weeks, all subjects stop medication and return for a final visit at week 20. All participants paid for visits with compensation available for travel.
Enroll Today

Chronic Idiopathic Urticaria

Otherwise known as chronic hives, this study is for anyone with unexplained hives lasting more than 6 weeks and not responding to over-the-counter antihistamines like Claritin, Zyrtec or Allegra.

Enroll Today

Urticaria (chronic hives)

Participants must be adults ages 18-75, have chronic spontaneous urticaria for more than 6 months while using at least one over the counter antihistamine daily (Zyrtec, Allegra or Claritin). This is a double-blind study of an injectable medication given every 4 weeks with 2 different doses vs placebo for 24 weeks. After 24 weeks, all subjects get active medicine. All participants paid for visits with compensation available for travel.
Enroll Today

Alopecia Areata

Autoimmune patchy or diffuse hair loss. This study is a registry to track symptoms and progress of patients who start on some of the newer immunosuppressive agents for treatment such as Olumiant or Litfulo.

Enroll Today

Bullous Pemphigoid

A rare autoimmune blistering condition that we are collecting blood samples to help a research lab identify potential allergy pathways in the disease. Newly diagnosed patients only.

Enroll Today

Enrollment Request Fivenson Dermatology Studies

Name(Required)
Clinical Trials(Required)
Please do not submit any Protected Health Information (PHI).
This field is for validation purposes and should be left unchanged.

Privacy Policy

Questions?

Please contact Laura Fader, at 734-222-9630 or lfader@fivensondermatology.com for more information.

To Learn More, Set Up Your Appointment Today

Fivenson Dermatology

Contact

phone: (734) 222-9630    fax: (734) 222-9631

3200 W Liberty Rd., Suite C5, Ann Arbor, MI 48103

Hours

After Hours

For non-emergency questions, use the patient portal or use the Contact Us form.

In case of emergency, call St. Joseph Mercy Hospital Operators at (734) 712-3456 and have Dr. Fivenson paged.